2021 tables: Institutions - biological sciences - corporate

The 2021 tables are based on Nature Index data from 1 January 2020 to 31 December 2020.

Table criteria

Request a badge Export CSV
# Institution Share 2019 Share 2020 Count 2020 Change in Adjusted Share* 2019–2020
1 BGI, China 9.12 7.34 50 -25.6%
2 China National Chemical Corporation (ChemChina), China 1.79 1.59 6 -17.8%
3 China National Pharmaceutical Group (Sinopharm), China – 1.04 3 N/A
4 Novogene Co., Ltd., China 0.34 0.84 12 127.0%
5 China State Shipbuilding Corporation Limited (CSSC), China 0.61 0.73 43 11.3%
6 Fosun Pharma, China – 0.71 1 N/A
7 Topchoice Group, China 0.85 0.64 10 -30.9%
8 GrandOmics Biosciences, China 0.30 0.61 2 85.1%
9 Tencent, China 0.20 0.60 3 179.7%
10 Mabwell (Shanghai) Bioscience Co., Ltd., China – 0.48 1 N/A
11 Singlera Genomics Inc., China 0.05 0.47 1 723.7%
11 Zhejiang NHU Company Ltd., China – 0.47 1 N/A
12 WuXi AppTec, China 0.57 0.45 9 -27.4%
13 Sinovac Biotech Co., Ltd., China 0.09 0.44 1 348.8%
14 Beijing Solidwill Sci-Tech Co., Ltd., China – 0.38 1 N/A
15 FiberHome Technologies Group, China 0.39 0.37 12 -13.4%
16 Hangzhou Dixiang Import & Export Co. Ltd, China – 0.31 1 N/A
17 Analytical Biosciences Limited, China – 0.28 3 N/A
18 Anhui Chungu 3D Institute of Intelligent Equipment and Industrial Technology, China – 0.25 1 N/A
19 Abmart Shanghai Co., Ltd., China – 0.24 1 N/A
20 AnchorDx Medical Co., Ltd., China – 0.24 1 N/A
21 Shanghai Celliver Biotechnology Co. Ltd., China – 0.24 1 N/A
22 Nextomics Biosciences Co., Ltd., China 0.45 0.23 2 -52.3%
23 Suzhou Abogen Biosciences Co., Ltd., China – 0.23 1 N/A
24 Guangzhou Wolbaki Biotech Co., Ltd., China 0.17 0.22 1 15.4%
25 Deepwise, China – 0.21 1 N/A
26 Biozeron Biotech Ltd., China – 0.20 1 N/A
26 Beijing Kawin Technology Co., Ltd., China – 0.20 1 N/A
26 Dongguan Enlife Stem Cell Biotechnology Institute, China – 0.20 1 N/A
26 EVOC Intelligent Technology Company Limited, China – 0.20 2 N/A
26 Shenzhen Mindray Bio-Medical Electronics Co., Ltd., China – 0.20 2 N/A
27 Huazhi Rice Bio-Tech Co., Ltd., China – 0.20 2 N/A
28 Hangzhou Repugene Technology Co., Ltd., China – 0.19 2 N/A
29 Annoroad Gene Technology Co., Ltd., China 0.17 0.19 4 4.6%
30 Geneplus-Beijing Institute, China 0.29 0.19 2 -39.6%
31 Pomona Biotechnology Corp., China – 0.19 1 N/A
31 Precision Scientific (Beijing) Co., Ltd., China – 0.19 1 N/A
32 Simcere Pharmaceutical Group, China – 0.18 2 N/A
33 Cipher Gene (Beijing) Co., Ltd., China – 0.18 3 N/A
34 Vazyme Biotech Co., Ltd., China – 0.17 1 N/A
35 Guangzhou nBiomed Ltd., China – 0.17 1 N/A
36 PTM Biolab Co., Ltd., China 0.05 0.17 1 223.7%
36 Berry Genomics Co., Ltd., China 0.09 0.17 1 69.6%
36 Eusyn Medical Technology Company, China – 0.17 1 N/A
36 Shanghai Omicsolution Co., Ltd., China – 0.17 1 N/A
37 Wuxi Biortus Biosciences Co., Ltd., China 0.17 0.16 2 -12.3%
38 Genscript Biotech Corporation, China – 0.15 2 N/A
39 WIMI Biotechnology Co., Ltd., China – 0.15 1 N/A
40 Pharchoice Therapeutics Inc., China 0.07 0.14 1 98.2%
40 Beijing Pangenomics Technology Co., Ltd. (Genetron Health), China 0.15 0.14 1 -10.8%
40 Beijing Ori-Gene Science and Technology Co., Ltd., China 0.15 0.14 1 -11.9%
40 Shanghai Model Organisms Center, Inc., China – 0.14 1 N/A
41 Shukun (Beijing) Technology Co., Ltd., China – 0.13 1 N/A
41 Gracell Biotechnologies (Shanghai) Co., Ltd., China – 0.13 1 N/A
41 Yahua Seeds Science Academy of Hunan, China – 0.13 1 N/A
42 China Resources (Holdings) Co., Ltd, China – 0.13 1 N/A
43 Alibaba Group Holding Limited, China 0.03 0.13 1 339.3%
43 Zhejiang DIAN Diagnostics Co., Ltd., China 0.06 0.13 1 85.0%
43 Bloomage Bio Technology Co., Ltd., China – 0.13 1 N/A
43 Guangdong Wens Foodstuff Group Co., Ltd., China – 0.13 1 N/A
44 Guangzhou Jinan Biomedicine Research and Development Center, China – 0.11 1 N/A
44 Guangdong Xinbaotang Biological Technology Co. Ltd., China – 0.11 1 N/A
44 ABLife, Inc., China – 0.11 1 N/A
44 Beijing Wantai Biological Pharmacy Enterprise CO., LTD., China – 0.11 1 N/A
44 Lifetech Scientific (Shenzhen) Co., Ltd., China – 0.11 1 N/A
45 LipidAll Technologies Co., Ltd., China 0.13 0.11 1 -19.6%
46 Qianyang Biomedical Research Institute, China 0.20 0.10 1 -52.9%
46 China National Tobacco Company (CNTC), China – 0.10 1 N/A
46 CARsgen Therapeutics Ltd., China – 0.10 1 N/A
46 Viva Biotech Ltd., China – 0.10 1 N/A
47 Biogle Genome Editing Center, China – 0.10 2 N/A
48 Genergy Bio-Technology (Shanghai) Co., China – 0.10 2 N/A
49 Hugobiotech Co., Ltd., China – 0.10 1 N/A
49 Shenzhen Puensum Genetech Institute, China – 0.10 1 N/A
50 Anhui Zhifei Longcom Biopharmaceutical Co., Ltd., China – 0.10 1 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.
  5. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2022 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.